Investing Profile
Amir Nashat
VCInvestor
Managing Partner at Polaris Venture Partners
polarispartners.com/partner/a...Cambridge, Massachusetts
Your Intro Paths to Amir Nashat
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Amir is a member of
NewCo Network
1586 CONNECTIONS
IT CRUX Mobile Apps Solutions Network
397 CONNECTIONS
University of California, Berkeley Network
362 CONNECTIONS
University of California, Berkeley Network
362 CONNECTIONS
Massachusetts Institute of Technology Network
248 CONNECTIONS
Find Amir Nashat on
cbCurrent Investing Position
Polaris Venture Partners Managing Partner
Investment Range
$300K - $2.0M
Sweet Spot
$500K
Investments On Record
59
Amir Nashat is on these Sector & Stage Rankings
BioTech (Series B)EnergyTech (Series B)EnergyTech (Series A)Consumer Internet (Series B)BioTech (Series A)Health IT (Series A)Health & Hospital Services (Series B)Health & Hospital Services (Series A)Boston / New EnglandDigital Health (Series B)Consumer Internet (Series A)Health IT (Series B)Digital Health (Series A)
Amir Nashat's Investments On Record (22)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Soufflé Therapeutics | Series AJan 2025$200M | $200M |
Matter Neuroscience | SeedFeb 2024$26M | $26M |
Freenome | Series FFeb 2024$250M Series DDec 2021$300M Series CAug 2020$270M Series BJul 2019$160M Series AAug 2017$7M Series AMar 2017$65M | $1.1B |
Jnana Therapeutics | Series CNov 2022$110M Series ADec 2017$50M | $160M |
Scholar Rock | Post Ipo EquityJun 2022$210M  Series CJan 2018$47M Series BJan 2016$36M Series ASep 2014$20M | $310M |
Dewpoint Therapeutics | Series CFeb 2022$150M Series BSep 2020$77M Series AJan 2019$60M | $290M |
Kojin Therapeutics | Series AJun 2021$60M | $60M |
Primmune Therapeutics | Series AOct 2020$27M | $27M |
Amir Nashat's Experience
Chief Executive Officer Paratus Sciences2023 - Present
Board Member Dewpoint Therapeutics2018 - Present
Board Member Morphic Therapeutic2017 - Present
Board Member Institute for Protein Innovation2017 - Present
Board Member CAMP4 Therapeutics2016 - Present
Board Member AgBiome2013 - Present
Board Member Scholar Rock2012 - Present
Managing Partner Polaris Venture Partners2002 - Present
Managing Partner Polaris Partners2002 - Present
Co-Founder HaeckelsPresent
Co-Founder Kojin TherapeuticsPresent
Board Member IT CRUX Mobile Apps SolutionsPresent
Co-Founder Village Pizza Tega CayPresent
Board Member Metacrine, Inc.2014 - 2023
Managing General Partner Polaris Venture Partners2002 - 2023
Managing General Partner Polaris Partners2002 - 2023
Board Member Syros Pharmaceuticals2014 - 2022
Board Member Freenome2019 - 2021
Chief Executive Officer Dewpoint Therapeutics2018 - 2020
Board Member Fate Therapeutics Inc2008 - 2020
Board Member Fate Therapeutics Inc.2008 - 2020
CEO Jnana Therapeutics2017 - 2018
Board Member Promedior, Inc.2008 - 2018
Board Member Receptos, Inc.2012 - 2014
Board Member NewCo2012 - 2014
Board Member Asset Management Group2012 - 2014
Board Member AVILA THERAPEUTICS, INC.2007 - 2012
Board Member Living Proof, Inc.2005 - 2011
CEO Living Proof, Inc.2005 - 2006
Amir Nashat's Education
Massachusetts Institute of Technology PhD Chemical Engineering
University of California, Berkeley MSc Materials Science Engineering
University of California, Berkeley BSc Mechanical Engineering
Investors who invest with Amir Nashat
Founders who looked at Amir Nashat's profile also looked at these Scouts & Angels